World News

No Additional Benefit From Tiragolumab Plus Atezolizumab Over Durvalumab in Locally...

Ogkologos - 24 Αυγούστου, 2026

EMA Recommends Extension of Indications for Datopotamab Deruxtecan

Ogkologos - 21 Αυγούστου, 2026

High-Dose Chemotherapy Followed by ASCT Improves Survival Compared with Non-myeloablative Consolidation...

Ogkologos - 20 Αυγούστου, 2026

ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment...

Ogkologos - 19 Αυγούστου, 2026

FDA Approves Isatuximab-irfc for Subcutaneous Injection for Multiple Myeloma Indications

Ogkologos - 19 Αυγούστου, 2026

Belzutifan Plus Lenvatinib Improves Outcomes Over Cabozantinib in Patients with Advanced...

Ogkologos - 18 Αυγούστου, 2026

Combining 177Lu-PSMA-617 with ADT Plus ARPI Prolongs rPFS in Patients with...

Ogkologos - 17 Αυγούστου, 2026

EMA Recommends Extension of Therapeutic Indications for Cetuximab

Ogkologos - 14 Αυγούστου, 2026

No OS Benefit from Continuous as Compared with Fixed-Duration Maintenance Therapy...

Ogkologos - 13 Αυγούστου, 2026

FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T...

Ogkologos - 12 Αυγούστου, 2026

1...8910...432 Σελίδα 9 από 432

MOST POPULAR

Jennifer Garner Shared A Video Of Her Mammogram Appointment

21 Οκτωβρίου, 2019

Foodie Fridays: Apple Bok Choy Salad

17 Σεπτεμβρίου, 2021

ESMO Immuno-Oncology Congress 2023, 6-8 December 2023, Geneva, Switzerland

29 Νοεμβρίου, 2023

How I Navigated Being a Young Mom During Cancer: A Survivor’s...

15 Φεβρουαρίου, 2023

Φόρτωση περισσοτέρων

No Additional Benefit From Tiragolumab Plus Atezolizumab Over Durvalumab in Locally...

EMA Recommends Extension of Indications for Datopotamab Deruxtecan

High-Dose Chemotherapy Followed by ASCT Improves Survival Compared with Non-myeloablative Consolidation...

ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment...

FDA Approves Isatuximab-irfc for Subcutaneous Injection for Multiple Myeloma Indications

Belzutifan Plus Lenvatinib Improves Outcomes Over Cabozantinib in Patients with Advanced...

Combining 177Lu-PSMA-617 with ADT Plus ARPI Prolongs rPFS in Patients with...

EMA Recommends Extension of Therapeutic Indications for Cetuximab

No OS Benefit from Continuous as Compared with Fixed-Duration Maintenance Therapy...

FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T...

MOST POPULAR

Jennifer Garner Shared A Video Of Her Mammogram Appointment

Foodie Fridays: Apple Bok Choy Salad

ESMO Immuno-Oncology Congress 2023, 6-8 December 2023, Geneva, Switzerland

How I Navigated Being a Young Mom During Cancer: A Survivor’s...

HOT NEWS

Changes to chromosomes impact how children’s brain tumours respond to treatment

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

Targeted Drug Approved for Acute Myeloid Leukemia with IDH1 Gene Mutations

Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ